Protective effects of 4-methylumbelliferone on myocardial ischemia/reperfusion injury in rats through inhibition of oxidative stress and downregulation of TLR4/NF-κB/NLRP3 signaling pathway

[1]  N. Aboutaleb,et al.  DNAzyme loaded nano-niosomes attenuate myocardial ischemia/reperfusion injury by targeting apoptosis, inflammation in a NF-κB dependent mechanism , 2023, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2]  N. Mishra,et al.  Inflammasome activation and formation of ASC specks in patients with juvenile idiopathic arthritis , 2023, Frontiers in Medicine.

[3]  Eman M. Saied,et al.  Dual targeting nanoparticles based on hyaluronic and folic acids as a promising delivery system of the encapsulated 4-Methylumbelliferone (4-MU) against invasiveness of lung cancer in vivo and in vitro. , 2022, International journal of biological macromolecules.

[4]  U. Himmelreich,et al.  'Myocardial Ischemia-Reperfusion Injury and the Influence of Inflammation. , 2022, Trends in cardiovascular medicine.

[5]  N. Fedorova,et al.  Inhibitor of Hyaluronic Acid Synthesis 4-Methylumbelliferone Suppresses the Secretory Processes That Ensure the Invasion of Neutrophils into Tissues and Induce Inflammation , 2022, Biomedicines.

[6]  S. Achenbach,et al.  Epidemiology of cardiovascular disease in Europe , 2021, Nature Reviews Cardiology.

[7]  Lei Peng,et al.  Boeravinone B alleviates gut dysbiosis during myocardial infarction‐induced cardiotoxicity in rats , 2021, Journal of cellular and molecular medicine.

[8]  Niek J. Pluijmert,et al.  Post-ischemic Myocardial Inflammatory Response: A Complex and Dynamic Process Susceptible to Immunomodulatory Therapies , 2021, Frontiers in Cardiovascular Medicine.

[9]  Bang-long Xu,et al.  Uric acid aggravates myocardial ischemia-reperfusion injury via ROS/NLRP3 pyroptosis pathway. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[10]  A. Coetzee,et al.  The Pathophysiology of Myocardial Ischemia and Perioperative Myocardial Infarction. , 2020, Journal of cardiothoracic and vascular anesthesia.

[11]  D. Vigetti,et al.  Involvement of hyaluronan in the adaptive changes of the rat small intestine neuromuscular function after ischemia/reperfusion injury , 2020, Scientific Reports.

[12]  G. Heusch.  Myocardial ischaemia–reperfusion injury and cardioprotection in perspective , 2020, Nature Reviews Cardiology.

[13]  M. Aslani,et al.  Correlation of Serum Adipolin with Epicardial Fat Thickness and Severity of Coronary Artery Diseases in Acute Myocardial Infarction and Stable Angina Pectoris Patients , 2020, Medical Principles and Practice.

[14]  V. Uddandrao,et al.  Therapeutic potential of biochanin-A against isoproterenol -induced myocardial infarction in rats. , 2020, Cardiovascular & hematological agents in medicinal chemistry.

[15]  R. Kitsis,et al.  Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease. , 2019, Physiological reviews.

[16]  A. Sahu,et al.  Role of MAPK/NF-κB pathway in cardioprotective effect of Morin in isoproterenol induced myocardial injury in rats , 2019, Molecular Biology Reports.

[17]  B. Joung,et al.  Extracellular Vesicles Derived from Hypoxic Human Mesenchymal Stem Cells Attenuate GSK3β Expression via miRNA-26a in an Ischemia-Reperfusion Injury Model , 2018, Yonsei medical journal.

[18]  P. Bullón,et al.  Cardiovascular diseases, NLRP3 inflammasome, and western dietary patterns , 2018, Pharmacological research.

[19]  J. D. de Haan,et al.  Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications , 2018, Front. Physiol..

[20]  Frédéric Barras,et al.  Oxidative stress, protein damage and repair in bacteria , 2017, Nature Reviews Microbiology.

[21]  B. Kuster,et al.  K+ Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Targeting Mitochondria. , 2016, Immunity.

[22]  Jingqing Yang,et al.  Radioprotective 105 kDa protein attenuates ischemia/reperfusion-induced myocardial apoptosis and autophagy by inhibiting the activation of the TLR4/NF-κB signaling pathway in rats. , 2016, International journal of molecular medicine.

[23]  J. Lieberman,et al.  Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores , 2016, Nature.

[24]  A. Mohamad,et al.  Antioxidant Activities of 4-Methylumbelliferone Derivatives , 2016, PloS one.

[25]  A. Bitto,et al.  ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury , 2016, Oxidative medicine and cellular longevity.

[26]  Kevin Yehl,et al.  Knockdown of TNF-α by DNAzyme gold nanoparticles as an anti-inflammatory therapy for myocardial infarction. , 2016, Biomaterials.

[27]  J. Bollyky,et al.  4-Methylumbelliferone Treatment and Hyaluronan Inhibition as a Therapeutic Strategy in Inflammation, Autoimmunity, and Cancer , 2015, Front. Immunol..

[28]  N. Voelkel,et al.  Independent roles of the priming and the triggering of the NLRP3 inflammasome in the heart. , 2015, Cardiovascular research.

[29]  Edward T Chouchani,et al.  Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS , 2014, Nature.

[30]  Mi-Kyung Lee,et al.  Long-term supplementation of umbelliferone and 4-methylumbelliferone alleviates high-fat diet induced hypertriglyceridemia and hyperglycemia in mice. , 2014, Chemico-biological interactions.

[31]  G. Christensen,et al.  The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury. , 2013, Cardiovascular research.

[32]  D. Yellon,et al.  Myocardial reperfusion injury: looking beyond primary PCI. , 2013, European heart journal.

[33]  Jeroen J. Bax,et al.  Third universal definition of myocardial infarction , 2013, Nature Reviews Cardiology.

[34]  A. Khanna,et al.  Wideband High‐Frequency Echocardiography to Evaluate Myocardial Infarct Size , 2009, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[35]  S. Naik,et al.  Cardioprotective activity of Ginkgo biloba Phytosomes in isoproterenol-induced myocardial necrosis in rats: a biochemical and histoarchitectural evaluation. , 2008, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[36]  Jun Yang,et al.  Sequential Expression of TLR4 and its Effects on the Myocardium of Rats with Myocardial Ischemia-Reperfusion Injury , 2008, Inflammation.

[37]  Zhi-Qing Zhao.  Oxidative stress-elicited myocardial apoptosis during reperfusion. , 2004, Current opinion in pharmacology.

[38]  M. Fenton,et al.  Toll-Like Receptor 4 and Toll-IL-1 Receptor Domain-Containing Adapter Protein (TIRAP)/Myeloid Differentiation Protein 88 Adapter-Like (Mal) Contribute to Maximal IL-6 Expression in Macrophages1 , 2002, The Journal of Immunology.

[39]  A. Harken,et al.  Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1β , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Liang Liu,et al.  Rg1 prevents myocardial hypoxia/reoxygenation injury by regulating mitochondrial dynamics imbalance via modulation of glutamate dehydrogenase and mitofusin 2. , 2016, Mitochondrion.

[41]  N. Frangogiannis,et al.  Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges. , 2016, Translational research : the journal of laboratory and clinical medicine.

[42]  Masafumi Takahashi.  NLRP3 inflammasome as a novel player in myocardial infarction. , 2014, International heart journal.